Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Calreticulin exposure increases cancer immunogenicity.

× No keyword cloud information.

23 in total

1. Modulatory role of calreticulin as chaperokine for dendritic cell-based immunotherapy.

Authors: A Bajor; S Tischer; C Figueiredo; M Wittmann; S Immenschuh; R Blasczyk; B Eiz-Vesper
Journal: Clin Exp Immunol Date: 2011-06-03 Impact factor: 4.330

2. Dendritic cell activation and maturation induced by recombinant calreticulin fragment 39-272.

Authors: Yue Li; Xiaoli Zeng; Lijuan He; Hui Yuan
Journal: Int J Clin Exp Med Date: 2015-05-15

3. Clostridium difficile toxin B intoxicated mouse colonic epithelial CT26 cells stimulate the activation of dendritic cells.

Authors: Tuxiong Huang; Gregorio Perez-Cordon; Lianfa Shi; Guangchao Li; Xingmin Sun; Xiaoning Wang; Jufang Wang; Hanping Feng
Journal: Pathog Dis Date: 2015-01-27 Impact factor: 3.166

4. The innate immune receptor Dectin-2 mediates the phagocytosis of cancer cells by Kupffer cells for the suppression of liver metastasis.

Authors: Yoshitaka Kimura; Asuka Inoue; Sho Hangai; Shinobu Saijo; Hideo Negishi; Junko Nishio; Sho Yamasaki; Yoichiro Iwakura; Hideyuki Yanai; Tadatsugu Taniguchi
Journal: Proc Natl Acad Sci U S A Date: 2016-11-21 Impact factor: 11.205

5. Calreticulin expression in the clonal plasma cells of patients with systemic light-chain (AL-) amyloidosis is associated with response to high-dose melphalan.

Authors: Ping Zhou; Julie Teruya-Feldstein; Ping Lu; Martin Fleisher; Adam Olshen; Raymond L Comenzo
Journal: Blood Date: 2007-11-02 Impact factor: 22.113

6. Association of HLA class I antigen abnormalities with disease progression and early recurrence in prostate cancer.

Authors: Barbara Seliger; Robert Stoehr; Diana Handke; Anja Mueller; Soldano Ferrone; Bernd Wullich; Andrea Tannapfel; Ferdinand Hofstaedter; Arndt Hartmann
Journal: Cancer Immunol Immunother Date: 2009-10-07 Impact factor: 6.968

Review 7. Calreticulin and cancer.

Authors: Mohammadreza Zamanian; Abhi Veerakumarasivam; Syahril Abdullah; Rozita Rosli
Journal: Pathol Oncol Res Date: 2013-02-08 Impact factor: 3.201

8. Calreticulin is a B cell molecular target in some gastrointestinal malignancies.

Authors: A Pekáriková; D Sánchez; L Palová-Jelínková; M Simsová; Z Benes; I Hoffmanová; P Drastich; I Janatková; T Mothes; H Tlaskalová-Hogenová; L Tucková
Journal: Clin Exp Immunol Date: 2009-12-17 Impact factor: 4.330

9. Antineoplastic activity of idazoxan hydrochloride.

Authors: G F Eilon; L Weisenthal; M Stupecky; G Landucci; L M Slater
Journal: Cancer Chemother Pharmacol Date: 2009-03-24 Impact factor: 3.333

10. Wogonin induced calreticulin/annexin A1 exposure dictates the immunogenicity of cancer cells in a PERK/AKT dependent manner.

Authors: Yong Yang; Xian-Jing Li; Zhen Chen; Xuan-Xuan Zhu; Jing Wang; Lin-bo Zhang; Lei Qiang; Yan-Jun Ma; Zhi-yu Li; Qing-Long Guo; Qi-Dong You
Journal: PLoS One Date: 2012-12-12 Impact factor: 3.240